slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 59,251-59,280
Pages 2,605
Rows per page 30
Component
59,251-59,280 of 78,138
05
The slide uses a Gantt-style visualization to show clinical trial phases for drug candidates.BioAtla | Investor Conference Presentation Deck | 15 slides · BioAtla
Conference presentation Investor relations 1 hit
13
The slide presents clinical trial data showing the efficacy of MDMA-assisted therapy compared to placebo, followed by the strategic rationale for a partnership.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations 1 hit
20
The slide uses a biological process diagram on the left and a scatter plot of mutation burden across cancer types on the right.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Solution OverviewLoop · Logic Chain1 hit
26
The chart uses a broken y-axis to show high-frequency outliers alongside the long tail of low-frequency targets.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
31
The slide uses a combination of microscopy images and a line chart to demonstrate efficacy.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
34
Includes schematic of lipid bilayer structure, RNA-lipoplex screening process, and bioluminescence imaging data.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
35
Includes chemical structure of PSAR-LNP components and a line chart comparing in vivo expression profiles.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
40
The slide uses a funnel to represent the reduction of candidates from exome variations to validated immunogenic neo-epitopes.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
42
The ROC curve shows the new model (blue) consistently outperforming the baseline NetMHCpan 4.1 EL (orange).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
43
The slide illustrates a multi-stage computational pipeline (Structural modeling -> EWS score -> ML modeling) and compares detection timing against WHO designations.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
44
The slide shows structural models of spike proteins (Wuhan, Beta, Omicron) alongside scatter plots correlating epitope alteration/semantic change/immune escape scores with pVNT50 reduction and ACE2 binding affinity.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
45
The chart displays genetic mutations (columns) against specific viral lineages (rows). Colors indicate mutation status (common vs. not common) and potentially other metrics.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
65
The slide uses a before-after framing to contrast efficacy and safety data.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
70
The chart compares baseline (Prevax 1MPD) vs post-vaccination GMTs for various BNT162b2 and Bivalent formulations.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
74
The slide uses a circular phylogenetic tree to illustrate the dominance of the Omicron clade (GRA) in recent outbreak sequences.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
75
The chart uses a highlighted box to focus on the Omicron period starting December 2021.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
77
Data shows neutralization titers for OMI and Bivalent vaccines against BA.1 and BA.4/5 variants.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
78
The chart uses a log scale for the y-axis (pVN50 titer).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
79
The chart shows that the Omi BA.4/5 and b2 + Omi BA.4/5 vaccines maintain higher neutralization ratios against Omicron sub-lineages compared to the original BNT162b2 vaccine.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
93
The slide uses a Gantt-style visualization for clinical trial phases.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
106
Kaplan-Meier plot showing significant difference in RFS between responders and non-responders.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
109
Includes a citation to a Nature article and specific trial results (Lipo-MERIT).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
110
The chart is a 'spider plot' or 'spaghetti plot' tracking individual patient lesion kinetics.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
111
The chart displays individual patient responses, categorized by treatment type and dose, with markers for partial response (PR) and stable disease (SD/irSD).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
116
Includes binding affinity data and a biological mechanism diagram.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
118
Data cut-off: August 31, 2020. MTD not reached.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
119
Waterfall plot displays individual patient responses categorized by cancer type and prior PD-(L)1 treatment status.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
12
The slide uses a vertical timeline/growth arrow to visualize the increasing percentage of DTC revenue.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
13
The slide uses a stacked bar chart to compare internal revenue performance against external market opportunity.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
18
The slide uses a McKinsey survey to frame the problem, then pivots to company-specific advantages.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit